<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="assignment of swabs and reagent for PCR testing during a" exact="viral" post="epidemicâ˜† SantiniAlberto[], pmc-release: 2020-9-9epub: 2020-9-9102341received: 2020-5-4rev-recd: 2020-9-3accepted: 2020-9-18(C) Elsevier"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="resource centre remains active. Highlights â€¢Large-scale quick testing is of" exact="primary" post="importance during a viral epidemic. â€¢Tests are hindered by"/>
 <result pre="Highlights â€¢Large-scale quick testing is of primary importance during a" exact="viral" post="epidemic. â€¢Tests are hindered by the lack of chemical"/>
 <result pre="Of particular interest for this work is the recent Coronavirus" exact="disease" post="2019 (COVID-19) pandemic. Under particular circumstances, a virus (and"/>
 <result pre="2019 (COVID-19) pandemic. Under particular circumstances, a virus (and the" exact="disease" post="it causes) can spread to a large part of"/>
 <result pre="spread to a large part of a population in a" exact="short" post="time, leading to an epidemic. When the epidemic spreads"/>
 <result pre="for example, possessed the right characteristics to turn its associated" exact="disease" post="into a pandemic: people carrying the virus do not"/>
 <result pre="44% of patients show no symptoms at all during the" exact="infection" post="period, making their diagnosis difficult [29]. Massive testing of"/>
 <result pre="health authorities can deploy to contain the spread of the" exact="disease" post="[37]. Viruses such as SARS-CoV-2 are RNA viruses, i.e.,"/>
 <result pre="with U and C with G). If the sample contains" exact="viral" post="RNA, it will pair with the chain injected by"/>
 <result pre="into double-strand DNA. To detect a significant presence of the" exact="viral" post="DNA, the genetic material goes through an amplification process,"/>
 <result pre="makers maximise the number of tests they can conduct while" exact="limited" post="by reagent availability and logistic constraints. Our main contributions"/>
 <result pre="advantage, vs. procuring reagent via sporadic shipments, even when the" exact="total" post="purchased quantity stays the same. Further, countries with limited"/>
 <result pre="the total purchased quantity stays the same. Further, countries with" exact="limited" post="lab infrastructure should prioritise acquiring more machines and training"/>
 <result pre="{ 1 , â€¦ , | R | } ," exact="limited" post="by their production capacity. Each factory rÂ âˆˆÂ R"/>
 <result pre="quantities qrg and qsw are global capacity limits on the" exact="total" post="amount of reagent and swab movements. Such an assumption"/>
 <result pre="number of swabs tested, it is possible to account for" exact="secondary" post="objectives. For example, because effective testing must be both"/>
 <result pre="planning, material requirement planning and supply chain optimisation (for a" exact="complete" post="overview on these topics see, e.g., Pochet and Wolsey"/>
 <result pre="multi-objective optimisation in which cost minimisation is tackled together with" exact="secondary" post="objectives, such as demand satisfaction [26], steadiness of production"/>
 <result pre="to provide an accurate estimate of the prevalence of the" exact="disease" post="among its population, while restricted by a nation-wide capacity"/>
 <result pre="the central lab limits, in this case, the number of" exact="total" post="expected positive results coming from all other labs in"/>
 <result pre="labâ€™s inventory at the start of the day and the" exact="total" post="amount received with, on the right-hand side, the inventory"/>
 <result pre="an optimal objective value, looks for the one optimising a" exact="secondary" post="objective (mean test waiting time). Let Z* be the"/>
 <result pre="minimising the average swab waiting time because (26) fixes the" exact="total" post="number of swabs tested. When minimising the primary objective,"/>
 <result pre="fixes the total number of swabs tested. When minimising the" exact="primary" post="objective, two untested swabs collected, respectively, on the first"/>
 <result pre="the time horizon would contribute the same penalty. Adding the" exact="secondary" post="objective avoids solution where old swabs remain untested for"/>
 <result pre="a planner can take to most increase testing capacity and" exact="lower" post="waiting times. The datasets and the code used are"/>
 <result pre="[18] with a time limit of 15 minutes for the" exact="primary" post="and 5 minutes for the secondary objective, on a"/>
 <result pre="15 minutes for the primary and 5 minutes for the" exact="secondary" post="objective, on a laptop equipped with a 4-core Intel"/>
 <result pre="across regions. Because swabs would need to move within a" exact="short" post="time (e.g., overnight) we put limitations on the inter-laboratory"/>
 <result pre="above. In particular, assuming that tests in Italy were largely" exact="limited" post="by the unavailability of reagent due to a poor"/>
 <result pre="13 36717 43582 18.70 56287 53.30 56287 53.30 56287 53.30" exact="Total" post="539942 617739 14.41 686759 27.19 709996 31.49 750464 38.99"/>
 <result pre="initial centroids for the regions (note how we excluded the" exact="external" post="boundary of S). We place the labs in S"/>
 <result pre="we aim at placing clusters in loose regional clusters. To" exact="complete" post="the assignment of labs to regions, we assign each"/>
 <result pre="a parameter. Note how Î»FPÂ Î»FPÂ â‰¥Â 1 drive the" exact="total" post="reagent production towards meeting the demand; in this case,"/>
 <result pre="on their release days, while grey background bars count the" exact="total" post="amount of reagent released on that day, by all"/>
 <result pre="making new reagent available twice per week produces an uneven" exact="total" post="daily distribution. Last, we introduce transshipment parameter Î»TS, which"/>
 <result pre="box plots, each box denotes the two central quartiles, the" exact="horizontal" post="line is the median, and whiskers extend to the"/>
 <result pre="regression analysis using the parameters as independent variables and the" exact="primary" post="(number of swabs tested, expressed as a percentage of"/>
 <result pre="(number of swabs tested, expressed as a percentage of the" exact="total" post="demand) and secondary (average waiting time of a swab"/>
 <result pre="tested, expressed as a percentage of the total demand) and" exact="secondary" post="(average waiting time of a swab before it is"/>
 <result pre="testing capabilities: for Î»LCÂ Î»LCÂ â‰¥Â 1, i.e., when the" exact="total" post="lab capacity is at least as large as the"/>
 <result pre="of swabs sent from one lab to another, over the" exact="total" post="number of swabs collected. The table shows the correlation"/>
 <result pre="wants to maximise the number of rRT-PCR tests during a" exact="viral" post="epidemic. After describing an Integer Programming model for a"/>
 <result pre="include real-life aspects of the organisation of healthcare systems. The" exact="complete" post="model takes into account that many countries manage healthcare"/>
 <result pre="forward reagent to other labs, i.e., enabling transshipments. On the" exact="short" post="term, increasing inter-regional collaboration requires political will and an"/>
 <result pre="antibodies which a person has developed in response to the" exact="viral infection." post="These tests are too slow for early detection of"/>
 <result pre="natural disaster relief: a simulation approachMed Decis Making323201247047610.1177/0272989X1243724722367795 6Center for" exact="Disease" post="Control and PreventionCDC 2019-Novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic"/>
 <result pre="Revision: 032020U.S.Â Department of Health and Human Services 7Center for" exact="Disease" post="Control and PreventionProcessing of sputum specimens for nucleic acid"/>
 <result pre="Italiana). 12Covid19Italia, Open data coronavirus, 2020, https://www.covid19italia.info/opendata/. 13European Centre for" exact="Disease" post="Prevention and ControlCoronavirus disease 2019 (COVID-19) pandemic: increased transmission"/>
 <result pre="coronavirus, 2020, https://www.covid19italia.info/opendata/. 13European Centre for Disease Prevention and ControlCoronavirus" exact="disease" post="2019 (COVID-19) pandemic: increased transmission in the EU/EEA and"/>
 <result pre="della situazione, 2020https://github.com/pcm-dpc/COVID-19. 33SancheS.LinY.T.XuC.Romero-SeversonE.HengartnerN.KeR.High contagiousness and rapid spread of severe" exact="acute" post="respiratory syndrome coronavirus 2Emerg infect Dis267202010.3201/eid2607.200282 34A. Santini, Increase"/>
 <result pre="situazione, 2020https://github.com/pcm-dpc/COVID-19. 33SancheS.LinY.T.XuC.Romero-SeversonE.HengartnerN.KeR.High contagiousness and rapid spread of severe acute" exact="respiratory" post="syndrome coronavirus 2Emerg infect Dis267202010.3201/eid2607.200282 34A. Santini, Increase COVID-19"/>
 <result pre="2020https://github.com/pcm-dpc/COVID-19. 33SancheS.LinY.T.XuC.Romero-SeversonE.HengartnerN.KeR.High contagiousness and rapid spread of severe acute respiratory" exact="syndrome" post="coronavirus 2Emerg infect Dis267202010.3201/eid2607.200282 34A. Santini, Increase COVID-19 swab"/>
 <result pre="COVID-19 emergency scenarioTechnical Report2020 37SoufS.Recent advances in diagnostic testing for" exact="viral" post="infectionsBiosci Horiz9201610.1093/biohorizons/hzw010 38Task force COVID-19 del Dipartimento Malattie Infettive"/>
 <result pre="epidemiological and clinical features of the emerging 2019 novel coronavirus" exact="pneumonia" post="(COVID-19) implicate special control measuresJ Med Virol926202056857610.1002/jmv.2574832134116 42J. Woodcock,"/>
</results>
